If bone marrow morphology and immunotypes reveal a typical APL phenotype but a negative PML::RARA fusion gene, variant APL needs to be identified through fusion gene screening and/or targeted RNA-sequencing as early as possible. The gene discussed is PML; the disease is acute promyelocytic leukemia.